![[logo] HealthTree Foundation](https://static.healthtree.org/icons/icon_spinner.svg){kind=icon}
![[logo] HealthTree Foundation](https://static.healthtree.org/logo_icon_only.svg){kind=icon}
Amir Fathi, MD
Leukemia Specialist
Specialities: Acute Myeloid Leukemia, Myelodysplastic Syndromes
Spoken languages: English
Clinical Expertise
- Acute Myeloid Leukemia
- Myelodysplastic Syndromes
About
Dr. Fathi focuses his research on the development and clinical translation of novel therapies for acute leukemias. He currently leads multiple clinical trials at the Dana Farber Harvard Cancer Center for patients with advanced leukemia and hematologic malignancies. He has a specific interest in studying FLT3 inhibition, aurora kinase inhibition, and antibody-drug conjugates as novel therapies.
Location
Massachusetts General Hospital: 55 Fruit St, Boston, MA 02114, USA
All HealthTree resources available anywhere, anytime
Download our App
Get the Latest Mantle Cell Lymphoma Updates, Delivered to You.
By subscribing to the HealthTree newsletter, you'll receive the latest research, treatment updates, and expert insights to help you navigate your health.
Download our App
HealthTree Foundation is a qualified 501(c)(3) tax-exempt organization.
Copyright © 2025 HealthTree Foundation. All rights reserved.
Tax ID 45-5354811